Insider · CIK 0001358285
Alan H Auerbach
ceopresidentofficerdirectorowner
Files at PBYI (PUMA BIOTECHNOLOGY, INC.). First filing Jan 3, 2025, latest Jan 8, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $478k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PBYI: PUMA BIOTECHNOLOGY, INC.
PBYIOct 9, 2026 · close 10.29
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 32Weak | PUMA BIOTECHNOLOGY, INC. | $205k 34,950 shares | -0% | +114% from low-5% from high | |
| 31Weak | PUMA BIOTECHNOLOGY, INC. | $167k 47,172 shares | -1% | +48% from low-4% from high | |
| 23Weak | PUMA BIOTECHNOLOGY, INC. | $107k 33,841 shares | -0% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | PBYI PUMA BIOTECHNOLOGY, INC. | AGrant or award Common Stock | +159,778 | $0.00 | $0 | 7,305,729 | Feb 20, 2026 |
| Feb 18, 2026 | PBYI PUMA BIOTECHNOLOGY, INC. | AGrant or award Stock Option (Right to Buy)derivative | +227,474 | $0.00 | $0 | 227,474 | Feb 20, 2026 |
| Jan 6, 2026 | PBYI PUMA BIOTECHNOLOGY, INC. | SOpen-market sale Common Stock10b5-1 | -16,938 | $5.84 | $99k | 7,163,963 | Jan 8, 2026 |
| Jan 7, 2026 | PBYI PUMA BIOTECHNOLOGY, INC. | SOpen-market sale Common Stock10b5-1 | -18,012 | $5.88 | $106k | 7,145,951 | Jan 8, 2026 |
| Jul 8, 2025 | PBYI PUMA BIOTECHNOLOGY, INC. | SOpen-market sale Common Stock10b5-1 | -25,592 | $3.53 | $90k | 7,202,481 | Jul 10, 2025 |
| Jul 9, 2025 | PBYI PUMA BIOTECHNOLOGY, INC. | SOpen-market sale Common Stock10b5-1 | -21,580 | $3.54 | $76k | 7,180,901 | Jul 10, 2025 |
| Feb 7, 2025 | PBYI PUMA BIOTECHNOLOGY, INC. | AGrant or award Common Stock | +198,399 | $0.00 | $0 | 7,228,073 | Feb 11, 2025 |
| Feb 7, 2025 | PBYI PUMA BIOTECHNOLOGY, INC. | AGrant or award Stock Option (Right to Buy)derivative | +274,622 | $0.00 | $0 | 274,622 | Feb 11, 2025 |
| Jan 2, 2025 | PBYI PUMA BIOTECHNOLOGY, INC. | SOpen-market sale Common Stock10b5-1 | -33,841 | $3.15 | $107k | 7,029,674 | Jan 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.